The role of CD8+ T-cells in lesion formation and axonal dysfunction in multiple sclerosis

REFERENCES

• Noseworthy JH, Lucchinetti C, Rodriguez M, et al. Multiple sclerosis. N Engl J Med 2000; 343: 938–952
   PubMed Web of Science ®Google Scholar
• Weinshenker BG. The natural history of multiple sclerosis: Update 1998. Semin Neurol 1998; 18: 301–307
   PubMed Web of Science ®Google Scholar
• Barkhof F. The clinico-radiological paradox in multiple sclerosis revisited. Curr Opin Neurol 2002; 15: 239–245
   PubMed Web of Science ®Google Scholar
• Bakshi R, Minagar A, Jaisani Z, et al. Imaging of multiple sclerosis: Role in neurotherapeutics. NeuroRx 2005; 2: 277–303
   PubMedGoogle Scholar
• Lucchinetti CF, Bruck W, Rodriguez M, et al. Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogen-esis. Brain Pathol 1996; 6: 259–274
   PubMed Web of Science ®Google Scholar
• Lucchinetti C, Bruck W, Parisi J, et al. Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelina-tion. Ann Neurol 2000; 47: 707–717
   PubMed Web of Science ®Google Scholar
• Davie CA, Barker GJ, Webb S, et al. Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss. Brain 1995; 118: 1583–1592
   PubMed Web of Science ®Google Scholar
• Losseff NA, Webb SL, O'Riordan JI, et al. Spinal cord atrophy and disability in multiple sclerosis. A new reproducible and sensitive MRI method with potential to monitor disease progression. Brain 1996; 119: 701–708
   PubMed Web of Science ®Google Scholar
• Sospedra M, Martin R. Immunology of multiple sclerosis. Annu Rev Immunol 2005; 23: 683–747
   PubMed Web of Science ®Google Scholar
• Kohm AP, Carpentier PA, Miller SD. Regulation of experimental autoimmune encephalomyelitis (EAE) by CD4+CD25+ regula-tory T cells. Novartis Found Symp 2003; 252: 45–52
   PubMedGoogle Scholar
• Lassmann H, Ransohoff RM. The CD4-Th1 model for multiple sclerosis: A critical [correction of crucial] re-appraisal. Trends Immunol 2004; 25: 132–137
   PubMed Web of Science ®Google Scholar
• Nelson AL, Bieber AJ, Rodriguez M. Contrasting murine models of MS. Int MS J 2004; 11: 95–99
   PubMedGoogle Scholar
• Babbe H, Roers A, Waisman A, et al. Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J Exp Med 2000; 192: 393–404
   PubMed Web of Science ®Google Scholar
• Skulina C, Schmidt S, Dornmair K, et al. Multiple sclerosis: Brain-infiltrating CD8+ T cells persist as clonal expansions in the cerebrospinal fluid and blood. Proc Natl Acad Sci USA 2004; 101: 2428–2433
   PubMed Web of Science ®Google Scholar
• Jacobsen M, Cepok S, Quak E, et al. Oligoclonal expansion of memory CD8+ T cells in cerebrospinal fluid from multiple sclerosis patients. Brain 2002; 125: 538–550
   PubMed Web of Science ®Google Scholar
• Ethell DW, Buhler LA. Fas ligand-mediated apoptosis in degen-erative disorders of the brain. J Clin Immunol 2003; 23: 363–370
   PubMed Web of Science ®Google Scholar
• Neumann H, Medana IM, Bauer J, et al. Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases. Trends Neurosci 2002; 25: 313–319
   PubMed Web of Science ®Google Scholar
• Lieberman J. The ABCs of granule-mediated cytotoxicity: New weapons in the arsenal. Nat Rev Immunol 2003; 3: 361–370
   PubMed Web of Science ®Google Scholar
• Trapani JA, Davis J, Sutton VR, et al. Proapoptotic functions of cytotoxic lymphocyte granule constituents in vitro and in vivo. Curr Opin Immunol 2000; 12: 323–329
   PubMed Web of Science ®Google Scholar
• Shresta S, Pham CT, Thomas DA, et al. How do cytotoxic lymphocytes kill their targets? Curr Opin Immunol 1998; 10: 581–587
   PubMed Web of Science ®Google Scholar
• Hoftberger R, Aboul-Enein F, Brueck W, et al. Expression of major histocompatibility complex class I molecules on the different cell types in multiple sclerosis lesions. Brain Pathol 2004; 14: 43–50
   PubMed Web of Science ®Google Scholar
• McCallum K, Esiri MM, Tourtellotte VVVV, et al. T cell subsets in multiple sclerosis. Gradients at plaque borders and differences in nonplaque regions. Brain 1987; 110: 1297–1308
   PubMed Web of Science ®Google Scholar
• Steinman L. Multiple sclerosis: A two-stage disease. Nat Immunol 2001; 2: 762–764
   PubMed Web of Science ®Google Scholar
• Woodroofe MN, Bellamy AS, Feldmann M, et al. Immunocytochemical characterisation of the immune reaction in the central nervous system in multiple sclerosis. Possible role for microglia in lesion growth. J Neurol Sci 1986; 74: 135–152
   PubMed Web of Science ®Google Scholar
• Bitsch A, da Costa C, Bunkowski S, et al. Identification of macrophage populations expressing tumor necrosis factor-alpha mRNA in acute multiple sclerosis. Acta Neuropathol (Berl) 1998; 95: 373–377
   PubMed Web of Science ®Google Scholar
• Gay FW, Drye TJ, Dick GW, et al. The application of multifactorial cluster analysis in the staging of plaques in early multiple sclerosis. Identification and characterization of the primary demyelinating lesion. Brain 1997; 120: 1461–1483
   PubMed Web of Science ®Google Scholar
• Booss J, Esiri MM, Tourtellotte VVVV, et al. Immunohistological analysis of T lymphocyte subsets in the central nervous system in chronic progressive multiple sclerosis. J Neurol Sci 1983; 62: 219–232
   PubMed Web of Science ®Google Scholar
• Huseby ES, White J, Crawford F, et al. How the T cell repertoire becomes peptide and MHC specific. Cell 2005; 122: 247–260
   PubMed Web of Science ®Google Scholar
• Wilson DB, Wilson DH, Schroder K, et al. Specificity and degeneracy of T cells. Mol Immunol 2004; 40: 1047–1055
   PubMed Web of Science ®Google Scholar
• Zang YC, Li S, Rivera VM, et al. Increased CD8+ cytotoxic T cell responses to myelin basic protein in multiple sclerosis. I Immunol 2004; 172: 5120–5127
   PubMed Web of Science ®Google Scholar
• Jurewicz A, Biddison WE, Antel JP. MHC class I-restricted lysis of human oligodendrocytes by myelin basic protein peptide-specific CD8 T lymphocytes. I Immunol 1998; 160: 3056–3059
   PubMed Web of Science ®Google Scholar
• Hollsberg P, Hansen HJ, Haahr S. Altered CD8+ T cell responses to selected Epstein-Barr virus immunodominant epitopes in patients with multiple sclerosis. Clin Exp Immunol 2003; 132: 137-143
   Google Scholar
• Scotet E, Peyrat MA, Saulquin X, et al. Frequent enrichment for CD8 T cells reactive against common herpes viruses in chronic inflammatory lesions: Towards a reassessment of the physiopatho-logical significance of T cell clonal expansions found in autoimmune inflammatory processes. Eur I Immunol 1999; 29: 973–985
   PubMed Web of Science ®Google Scholar
• Cepok S, Zhou D, Srivastava R, et al. Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis. J Clin Invest 2005; 115: 1352–1360
   PubMed Web of Science ®Google Scholar
• Bruck W, Stadelmann C. Inflammation and degeneration in multiple sclerosis. Neurol Sci 2003; 24 (Suppl. 5): S265—S267
   Google Scholar
• Bjartmar C, Wujek JR, Trapp BD. Axonal loss in the pathology of MS: Consequences for understanding the progressive phase of the disease. I Neurol Sci 2003; 206: 165–171
   PubMed Web of Science ®Google Scholar
• Bjartmar C, Trapp BD. Axonal degeneration and progressive neurologic disability in multiple sclerosis. Neurotox Res 2003; 5: 157-164
   Google Scholar
• Rivera-Quinones C, McGavern D, Schmelzer JD, et al. Absence of neurological deficits following extensive demyelination in a class I-deficient murine model of multiple sclerosis. Nat Med 1998; 4: 187–193
   PubMed Web of Science ®Google Scholar
• Black JA, Felts P, Smith KJ, et al. Distribution of sodium channels in chronicallydemyel inatedspinalcordaxons:Immunoultrastructural localization and electrophysiological observations. Brain Research 544 (1991) 59-70. Brain Res 1997; 761: 1
   PubMed Web of Science ®Google Scholar
• Moll C, Mourre C, Lazdunski M, et al. Increase of sodium channels in demyelinated lesions of multiple sclerosis. Brain Res 1991; 556: 311–316
   PubMed Web of Science ®Google Scholar
• Andrews HE, Nichols PP, Bates D, et al. Mitochondrial dysfunction plays a key role in progressive axonal loss in Multiple Sclerosis. Med Hypotheses 2005; 64: 669–677
   PubMed Web of Science ®Google Scholar
• Dahl D, Perides G, Bignami A. Axonal regeneration in old multiple sclerosis plaques. Immunohistochemical study with monoclonal antibodies to phosphorylated and non-phosphorylated neurofila-ment proteins. Acta Neuropathol (Berl) 1989; 79: 154–159
   PubMed Web of Science ®Google Scholar
• Trapp BD, Peterson J, Ransohoff RM, et al. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998; 338: 278-285
   Google Scholar
• Narayanan S, Fu L, Pioro E, et al. Imaging of axonal damage in multiple sclerosis: Spatial distribution of magnetic resonance imaging lesions. Ann Neurol 1997; 41: 385–391
   PubMed Web of Science ®Google Scholar
• van Waesberghe JH, Kamphorst W, De Groot CJ, et al. Axonal loss in multiple sclerosis lesions: Magnetic resonance imaging insights into substrates of disability. Ann Neurol 1999; 46: 747–754
   PubMed Web of Science ®Google Scholar
• Matthews PM, De Stefano N, Narayanan S, et al. Putting magnetic resonance spectroscopy studies in context: Axonal damage and disability in multiple sclerosis. Semin Neurol 1998; 18: 327–336
   PubMed Web of Science ®Google Scholar
• De Stefano N, Matthews PM, Antel JP, et al. Chemical pathology of acute demyelinating lesions and its correlation with disability. Ann Neurol 1995; 38: 901–909
   PubMed Web of Science ®Google Scholar
• De Stefano N, Matthews PM, Narayanan S, et al. Axonal dysfunction and disability in a relapse of multiple sclerosis: Longitudinal study of a patient. Neurology 1997; 49: 1138–1141
   PubMed Web of Science ®Google Scholar
• De Stefano N, Narayanan S, Matthews PM, et al. In vivo evidence for axonal dysfunction remote from focal cerebral demyelination of the type seen in multiple sclerosis. Brain 1999; 122: 1933–1939
   PubMed Web of Science ®Google Scholar
• Narayana PA, Doyle TJ, Lai D, et al. Serial proton magnetic resonance spectroscopic imaging, contrast-enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis. Ann Neurol 1998; 43: 56–71
   PubMed Web of Science ®Google Scholar
• De Stefano N, Narayanan S, Francis GS, et al. Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability. Arch Neurol 2001; 58: 65–70
   PubMed Web of Science ®Google Scholar
• Fu L, Matthews PM, De Stefano N, et al. Imaging axonal damage of normal-appearing white matter in multiple sclerosis. Brain 1998; 121: 103–113
   PubMed Web of Science ®Google Scholar
• Bitsch A, Schuchardt J, Bunkowski S, et al. Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflamma-tion. Brain 2000; 123: 1174–1183
   PubMed Web of Science ®Google Scholar
• Bien CG, Bauer J, Deckwerth TL, et al. Destruction of neurons by cytotoxic T cells: A new pathogenic mechanism in Rasmussen's encephalitis. Ann Neurol 2002; 51: 311–318
   PubMed Web of Science ®Google Scholar
• Tanaka M, Tanaka K, Shinozawa K, et al. Cytotoxic T cells react with recombinant Yo protein from a patient with paraneoplastic cerebellar degeneration and anti-Yo antibody. J Neurol Sci 1998; 161: 88–90
   PubMed Web of Science ®Google Scholar
• Neumann H, Cavalie A, Jenne DE, et al. Induction of MHC class I genes in neurons. Science 1995; 269: 549–552
   PubMed Web of Science ®Google Scholar
• Medana I, Martinic MA, Wekerle H, et al. Transection of major histocompatibility complex class I-induced neurites by cytotoxic T lymphocytes. Am] Pathol 2001; 159: 809–815
   PubMed Web of Science ®Google Scholar
• Tsunoda I, Fujinami RS. Two models for multiple sclerosis: Experimental allergic encephalomyelitis and Theiler's murine encephalomyelitis virus. I Neuropathol Exp Neurol 1996; 55: 673–686
   PubMed Web of Science ®Google Scholar
• Crawford MP, Yan SX, Ortega SB, et al. High prevalence of autoreactive, neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay. Blood 2004; 103: 4222–4231
   PubMed Web of Science ®Google Scholar
• Tsuchida T, Parker KC, Turner RV, et al. Autoreactive CD8+ T-cell responses to human myelin protein-derived peptides. Proc Natl Acad Sci USA 1994; 91: 10859–10863
   PubMed Web of Science ®Google Scholar
• Huseby ES, Liggitt D, Brabb T, et al. A pathogenic role for myelin-specific CD8(+) T cells in a model for multiple sclerosis. I Exp Med 2001; 194: 669–676
   PubMed Web of Science ®Google Scholar
• Sun D, Whitaker JN, Huang Z, et al. Myelin antigen-specific CD8+ T cells are encephalitogenic and produce severe disease in C57BL/6 mice. J Immunol 2001; 166: 7579–7587
   PubMed Web of Science ®Google Scholar
• Ford ML, Evavold BD. Specificity, magnitude, and kinetics of MOG-specific CD8+ T cell responses during experimental autoimmune encephalomyelitis. Eur J Immunol 2005; 35: 76–85
   PubMed Web of Science ®Google Scholar
• Ure DR, Rodriguez M. Preservation of neurologic function during inflammatory demyelination correlates with axon sparing in a mouse model of multiple sclerosis. Neuroscience 2002; 111:399–411
   PubMed Web of Science ®Google Scholar
• Murray PD, McGavern DB, Lin X, et al. Perforin-dependent neurologic injury in a viral model of multiple sclerosis. J Neurosci 1998; 18: 7306–7314
   PubMed Web of Science ®Google Scholar
• Johnson AJ, Upshaw J, Pavelko KD, et al. Preservation of motor function by inhibition of CD8+ virus peptide-specific T cells in Theiler's virus infection. FASEB J 2001; 15: 2760–2762
   PubMed Web of Science ®Google Scholar